This funding opportunity encourages research projects that utilize the unique PLCO biorepository, including serial pre-diagnostic blood samples and buccal cells, to study cancer etiology and discover or validate early detection biomarkers. Projects must involve PLCO biospecimens and can include biochemical and genetic analyses of cancer risk, leveraging associated demographic and clinical data.
Eligible applicants include a wide range of organizations such as state and local governments, tribal organizations, small businesses, nonprofits, institutions of higher education, and various federally recognized and community-based entities. Non-U.S. entities are also eligible.
